Meta-analysis of primary endpoint of Grass MATA MPL field studies with optimized dose and treatment regimen of PQ Grass 27600 SU

Pneumologie 2025; 79(S 01): S12-S13
DOI: 10.1055/s-0045-1804563

Abstracts

A1 – Asthma, Allergologie & Immunologie

Authors

S Zielen

¹Dept Children and Adolescents; Allergology, Pulmonology and Cystic Fibrosis, Goethe University
M Cuevas

²Praxis für Hals-, Nasen-, Ohrenheilkunde und Allergologie, Freital, Germany
P DeKam

²Allergy Therapeutics
M Kramer

²Allergy Therapeutics
M Skinner

²Allergy Therapeutics
F Sellwood

²Allergy Therapeutics